Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
SC-43 and Cisplatin in Advanced NSCLC or BTC
NCT04733521Phase 2Unknown
- Sponsor
- RaND Biosciences
- Start
- May 2021
- Primary completion
- Sep 2023
- Modality
- Small Molecules
01
Overview
A Phase 2 trial of SC-43 in non-small cell lung cancer (NSCLC), biliary tract cancer (BTC), sponsored by RaND Biosciences. Status: unknown.
02
Drugs
SC-43
03
Conditions
non-small cell lung cancer (NSCLC)biliary tract cancer (BTC)
Beyond the preview
Go deeper on NCT04733521.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04733521.